Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.78 - $32.48 $3.22 Million - $4.22 Million
-129,833 Reduced 27.34%
345,050 $8.55 Million
Q1 2024

May 15, 2024

BUY
$32.2 - $42.44 $15.3 Million - $20.2 Million
474,883 New
474,883 $15.3 Million
Q4 2023

Feb 12, 2024

BUY
$31.87 - $40.71 $15.8 Million - $20.2 Million
495,217 New
495,217 $20.1 Million
Q3 2023

Nov 14, 2023

SELL
$34.17 - $42.98 $1.64 Million - $2.07 Million
-48,064 Reduced 9.16%
476,665 $16.5 Million
Q2 2023

Aug 14, 2023

BUY
$37.4 - $44.52 $4.08 Million - $4.86 Million
109,114 Added 26.25%
524,729 $21.3 Million
Q1 2023

May 12, 2023

SELL
$36.5 - $48.0 $1.16 Million - $1.52 Million
-31,752 Reduced 7.1%
415,615 $16.1 Million
Q4 2022

Feb 13, 2023

SELL
$37.44 - $46.51 $383,984 - $477,006
-10,256 Reduced 2.24%
447,367 $19.9 Million
Q3 2022

Nov 14, 2022

BUY
$42.27 - $57.6 $18.2 Million - $24.8 Million
430,429 Added 1582.81%
457,623 $19.5 Million
Q2 2022

Aug 15, 2022

BUY
$52.3 - $71.59 $555,373 - $760,214
10,619 Added 64.07%
27,194 $1.52 Million
Q1 2022

May 16, 2022

BUY
$51.32 - $68.5 $15,036 - $20,070
293 Added 1.8%
16,575 $1.03 Million
Q4 2021

Feb 11, 2022

BUY
$47.03 - $57.12 $765,742 - $930,027
16,282 New
16,282 $898,000
Q1 2021

May 17, 2021

SELL
$76.15 - $111.94 $3.76 Million - $5.52 Million
-49,353 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$96.85 - $148.25 $59,465 - $91,025
-614 Reduced 1.23%
49,353 $4.89 Million
Q3 2020

Nov 16, 2020

SELL
$122.47 - $213.56 $847,859 - $1.48 Million
-6,923 Reduced 12.17%
49,967 $7.09 Million
Q2 2020

Aug 14, 2020

SELL
$185.52 - $231.25 $13.4 Million - $16.7 Million
-72,043 Reduced 55.88%
56,890 $11.2 Million
Q1 2020

May 14, 2020

SELL
$143.0 - $274.03 $23.7 Million - $45.4 Million
-165,838 Reduced 56.26%
128,933 $25.3 Million
Q4 2019

Feb 11, 2020

BUY
$146.12 - $215.82 $43.1 Million - $63.6 Million
294,771 New
294,771 $61 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.69B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.